Internal medicine
Service
TRIUMF
Vancouver, CanadáPublications in collaboration with researchers from TRIUMF (19)
2011
-
Age-specific progression of nigrostriatal dysfunction in Parkinson's disease
Annals of Neurology, Vol. 69, Núm. 5, pp. 803-810
-
Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease
Brain, Vol. 134, Núm. 11, pp. 3290-3298
2010
-
Dopamine transporter PET in normal aging: Dopamine transporter decline and its possible role in preservation of motor function
Synapse, Vol. 64, Núm. 2, pp. 146-151
-
Dopamine turnover increases in asymptomatic LRRK2 mutations carriers
Movement Disorders, Vol. 25, Núm. 16, pp. 2717-2723
-
Effects of expectation on placebo-induced dopamine release in Parkinson disease
Archives of General Psychiatry, Vol. 67, Núm. 8, pp. 857-865
2009
-
Dopamine transporter relation to levodopa-derived synaptic dopamine in a rat model of Parkinson's: An in vivo imaging study
Journal of Neurochemistry, Vol. 109, Núm. 1, pp. 85-92
-
Longitudinal progression of sporadic Parkinson's disease: A multi-tracer positron emission tomography study
Brain, Vol. 132, Núm. 11, pp. 2970-2979
-
PET demonstrates reduced dopamine transporter expression in PD with dyskinesias
Neurology, Vol. 72, Núm. 14, pp. 1211-1216
-
Visualizing vesicular dopamine dynamics in Parkinson's disease
Synapse, Vol. 63, Núm. 8, pp. 713-716
2007
-
Dopamine transporter relation to dopamine turnover in Parkinson's disease: A positron emission tomography study
Annals of Neurology, Vol. 62, Núm. 5, pp. 468-474
2004
-
Changes of dopamine turnover in the progression of Parkinson's disease as measured by positron emission tomography: Their relation to disease-compensatory mechanisms
Journal of Cerebral Blood Flow and Metabolism, Vol. 24, Núm. 8, pp. 869-876
-
Impact of the spatial normalization template and realignment procedure on the SPM analysis of [11C]raclopride PET studies
IEEE Transactions on Nuclear Science, Vol. 51, Núm. 1 I, pp. 205-211
-
Lack of regional selectivity during the progression of Parkinson disease: Implications for pathogenesis
Archives of Neurology, Vol. 61, Núm. 12, pp. 1920-1925
2003
-
Age and severity of nigrostriatal damage at onset of Parkinson's disease
Synapse, Vol. 47, Núm. 2, pp. 152-158
-
Effect of dopamine loss and the metabolite 3-O-methyl-[18F]fluoro-dopa on the relation between the 18F-fluorodopa tissue input uptake rate constant Kocc and the [18F]fluorodopa plasma input uptake rate constant Ki
Journal of Cerebral Blood Flow and Metabolism, Vol. 23, Núm. 3, pp. 301-309
-
VMAT2 binding is elevated in dopa-responsive dystonia: Visualizing empty vesicles by PET
Synapse, Vol. 49, Núm. 1, pp. 20-28
2002
-
Dopamine release in human ventral striatum and expectation of reward
Behavioural Brain Research, Vol. 136, Núm. 2, pp. 359-363
-
Impact of Different Realignment Algorithms on the SPM Analysis of [ 11C]Raclopride PET Studies
IEEE Nuclear Science Symposium and Medical Imaging Conference
2000
-
In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease
Annals of Neurology, Vol. 47, Núm. 4, pp. 493-503